title: TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
authors.affiliation: Department of Oncology, University Hospital Antwerp, Belgium.
authors.forename: A T
authors.initials: AT
authors.lastname: Van Oosterom
authors.forename: J P
authors.initials: JP
authors.lastname: Droz
authors.forename: S T
authors.initials: ST
authors.lastname: Fossa
authors.forename: A V
authors.initials: AV
authors.lastname: Bono
authors.forename: T A
authors.initials: TA
authors.lastname: Splinter
authors.forename: A J
authors.initials: AJ
authors.lastname: Verbaeys
authors.forename: J
authors.initials: J
authors.lastname: Keizer
authors.forename: M
authors.initials: M
authors.lastname: De Pauw
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013654:Taurine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D013654:Taurine; C052991:1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea